BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15800448)

  • 1. [Polyneuropathy associated with neurofibromatosis].
    Drouet A; Créange A
    Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis 1-associated neuropathies: a reappraisal.
    Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
    Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis: part 2--clinical management.
    Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
    Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seizures in neurofibromatosis. What is the risk?].
    Drouet A
    Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
    Plotkin SR; Bredella MA; Cai W; Kassarjian A; Harris GJ; Esparza S; Merker VL; Munn LL; Muzikansky A; Askenazi M; Nguyen R; Wenzel R; Mautner VF
    PLoS One; 2012; 7(4):e35711. PubMed ID: 22558206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).
    Ferner RE; Hughes RA; Hall SM; Upadhyaya M; Johnson MR
    J Med Genet; 2004 Nov; 41(11):837-41. PubMed ID: 15520408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound assessment of peripheral nerve pathology in neurofibromatosis type 1 and 2.
    Winter N; Rattay TW; Axer H; Schäffer E; Décard BF; Gugel I; Schuhmann M; Grimm A
    Clin Neurophysiol; 2017 May; 128(5):702-706. PubMed ID: 28315612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of neurofibromatosis type 2 (NF2) presenting with late-onset axonal polyneuropathy].
    Iseki C; Takahashi Y; Wada M; Kawanami T; Kurita K; Kato T
    Rinsho Shinkeigaku; 2009 Jul; 49(7):419-23. PubMed ID: 19715170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
    Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
    Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatoses: part 1 - diagnosis and differential diagnosis.
    Rodrigues LO; Batista PB; Goloni-Bertollo EM; de Souza-Costa D; Eliam L; Eliam M; Cunha KS; Darrigo-Junior LG; Ferraz-Filho JR; Geller M; Gianordoli-Nascimento IF; Madeira LG; Malloy-Diniz LF; Mendes HM; de Miranda DM; Pavarino EC; Baptista-Pereira L; Rezende NA; Rodrigues Lde O; da Silva CM; de Souza JF; de Souza ML; Stangherlin A; Valadares ER; Vidigal PV
    Arq Neuropsiquiatr; 2014 Mar; 72(3):241-50. PubMed ID: 24676443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different forms of neurofibromatosis.
    Ruggieri M
    Childs Nerv Syst; 1999 Jul; 15(6-7):295-308. PubMed ID: 10461778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatous neuropathy: An ultrastructural study.
    Terracciano C; Pachatz C; Rastelli E; Pastore FS; Melone MAB; Massa R
    Ultrastruct Pathol; 2018; 42(3):312-316. PubMed ID: 29583067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
    Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
    Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple cutaneous plexiform schwannomas. Report of a case and review of the literature with particular reference to the association with types 1 and 2 neurofibromatosis and schwannomatosis.
    Reith JD; Goldblum JR
    Arch Pathol Lab Med; 1996 Apr; 120(4):399-401. PubMed ID: 8619756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis-associated nerve sheath tumors. Case report and review of the literature.
    Murovic JA; Kim DH; Kline DG
    Neurosurg Focus; 2006 Jan; 20(1):E1. PubMed ID: 16459989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.